88 results
PRE 14C
NMRD
Nemaura Medical Inc
19 Apr 24
Preliminary information
4:05pm
that the Reverse Split, if completed, will result in the intended benefits described above, that the market price of our common stock will increase following … to select the Reverse Split ratio that it believes will be most likely to achieve the anticipated benefits of the Reverse Split described above. The Reverse
8-K
EX-10.1
NMRD
Nemaura Medical Inc
10 Apr 24
Entry into a Material Definitive Agreement
4:16pm
and the mutual benefits to the Parties to be derived herefrom, and for other good and valuable consideration, the receipt and sufficiency of which are hereby
8-K
EX-99.1
NMRD
Nemaura Medical Inc
3 Jan 24
Important Update on Listing Status and Strategic Direction
7:00am
.
Benefits of the OTC Markets:
The transition to the OTC Markets will provide operational flexibility, reduced compliance costs, and the ability
8-K
EX-10.3
9d3uqi
21 Nov 23
Nemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility to Fuel Strategic Growth
8:38am
8-K
EX-10.1
ec3jh
21 Nov 23
Nemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility to Fuel Strategic Growth
8:38am
424B8
vnf34u kk
11 Sep 23
Prospectus unintentially filed late
4:41pm
PRE 14A
4jx8c09 ovb
10 Aug 23
Preliminary proxy
4:05pm
POS AM
jdhdtn1xvgu4 ms
3 Aug 23
Prospectus update (post-effective amendment)
4:08pm
424B4
mll izj4ali
15 May 23
Prospectus supplement with pricing info
4:31pm